Member Info for Aldebaran

These little mini bounces in an overall downtrend are perfect to sell into as indeed many are.

?

This chart is looking really strong for those of you into that sort of thing. Clearly fueld by the ongoing buybacks and recently announced redemption indicating lloyds are in a really strong financial and stable position.

I believe we're looking at 90p being hit here sooner than later. Reverse head and shoulders chart pattern, rising momentum and yet still nowhere near being overbrought technically.

Good volume

Bullish candles

Reverse head and shoulders

Company buying back shared

Future looks bright here

Added

Looks like a dead cat bounce to me at the 50% fib perfect for selling into

Https://www.mediscience-event.co.uk/nominations-overview/

Avacta, hvivo and hemo who is most likely to win? Event attended by all the right people should be exciting

So bearded dragon are you now saying 270p was the bottom?

U all assume I say it will go down in a straight line. Wrong. Yes it pumped after last time but while u guys where screaming buy at over 600p I was waiting for inevitable drop. Never said it will go in a straight line but it will hit 140p it's like a magnet pulling price there

Nonsense. Just because something is technically oversold on one indicator does not mean a strong rally is inevitable etc that is a huge steaming pile of bull shhhhh it.

Maybe you believe it or maybe you are misleading others on purpose I don't no but what I do no is that this is way overvalued never turned a profit and technically it has just been pumped with the dump to 140p underway

Why does this have a price target lower than today's price? I don't get it. Anyone?

Maybe Alde was right...

Amazon were on track to be profitable though is audiboom?

I am not clear all I see is ebitda blah blah blah it's been going how long now and still unable to convert revenue to cash and no idea or projection when this will be done.

Someone said 295p was definitely the bottom the other day. Just constantly wrong. It's been pumped and dumped like I said. Tobin is clueless. Anyone following him is heavily underwater now

Wasn't 295p the bottom ?

Guess not.

140p is where this is headed

Peptide drug conjugates are like 10% the price of ADC's this puts more pressure on ADC's and more benefit of PDC's. That's even if these price changed impact chemo does anyone no for sure that it does?

Suspiciously slow p1b?

Erm if a deal is based around p1b data than I'd rather it was accurate and exceptional than fast and leaving efficacy on the table just to ease the concerns of a few weirdo obsessed anonymous bulletin bored nutters.

The breast oncologists were dying to get there hands on 6k, and Dr tap knows how good it is in STS plus the SGC results speak for themselves.

If enrolment is slow it is because avacta are dictating the pace by only selecting high fap slfn11 patients who are practically guaranteed to respond well to this drug. IG enrolment is slow that is.

And that is right thing to do. It will ensure p1b results are the best they can be which sets us up for a strong negotiation and good position.

Just looking at this from a trading opportunity but I'm reluctant to buy due to the bearish chart pattern that has formed. A triple top and with a gap to fill to 58p I think it will head their so is probably best place to take a long trade from risk reward perspective. Anyone else trade this have any views?

It's common sense not gibberish I can read numbers very good tho and boom numbers make for pour reading

Had this with another chat so English isn't my first language nevermind anyway debate my point not my English literature

Gapped down this morning. Anyone thinking 295 was the bottom is just wishful thinking.

For those saying I show up when price is down guys the price has been in a multi year downtrend. Apart from the odd dead cat bounce or pump and dump like we have had recently.

Tobins buys have become nothing but a liquidity event to cell into. I honestly for the life off me do not understand the hipe around this stock at this price. Nowhere near profitable and been going how long? It's not all about revenue it's about free cashflow. More they earn the more podcasters want. There will never be any profits in this business or not for a long time therefore it will be valued all over the place based of sentiment.

People need to be weary here like I say 140p looks a dead cert even if it doesn't go their in a straight line

So far away from either being sold or profitable with huge clinical risks along the way. Even if successful how many shares will be in circulation by the time the key point comes? Looks like current sharheolde will be diluted to oblivion before this is commercialised IF it is commercialised. Most trials fail so very high risk of that happening and this becoming a zero.

Why are people invested here at this point again I am struggling to understand investment case